Does SIPONIMOD Cause Mobility decreased? 179 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 179 reports of Mobility decreased have been filed in association with SIPONIMOD (MAYZENT). This represents 2.1% of all adverse event reports for SIPONIMOD.
179
Reports of Mobility decreased with SIPONIMOD
2.1%
of all SIPONIMOD reports
2
Deaths
61
Hospitalizations
How Dangerous Is Mobility decreased From SIPONIMOD?
Of the 179 reports, 2 (1.1%) resulted in death, 61 (34.1%) required hospitalization, and 4 (2.2%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIPONIMOD. However, 179 reports have been filed with the FAERS database.
What Other Side Effects Does SIPONIMOD Cause?
Fatigue (958)
Headache (862)
Dizziness (654)
Gait disturbance (506)
Multiple sclerosis relapse (504)
Fall (478)
Multiple sclerosis (455)
Lymphocyte count decreased (398)
Nausea (397)
Drug ineffective (396)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which SIPONIMOD Alternatives Have Lower Mobility decreased Risk?
SIPONIMOD vs SIPULEUCEL-T
SIPONIMOD vs SIROLIMUS
SIPONIMOD vs SIRUKUMAB
SIPONIMOD vs SITAGLIPTIN
SIPONIMOD vs SKYLA